Elixir announced the launch of a specialty generic medication enhancement to our suite of solutions effective June 1,...
Read MoreElixir
Recent Posts
With the growing specialty drug pipeline that is contributing to nearly half of overall drug spend, we have been...
Read MoreThe role of the Clinical Account Executive (CAE) at Elixir is a very important one for helping clients identify...
Read MoreApproximately 40% of Americans will be diagnosed with some type of cancer in their lifetime. Many cancer treatments...
Read MoreThis February, Centers for Medicare and Medicaid Services (CMS) announced an update to the Medicare Communications and...
Read MoreIn our four-part series on specialty drug management, we have covered the importance of monitoring drugs before FDA...
Read MoreDiabetes is a growing concern in the United States, with 35 million individuals impacted by type 2 diabetes mellitus...
Read MoreThere is no cure for the debilitating disease multiple sclerosis (MS); however, there are treatments that can slow...
Read MoreLike everything in the healthcare industry, the pharmacy space is continually changing, from regulations to pharmacy...
Read MoreContinuing our four-part series on specialty drug management, we first discussed the importance of monitoring drugs...
Read More